DOCSLIB.ORG

The Adverse Effects of the Methoxsalen and Ultraviolent a Radiation on Spermatogenesis in Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Adverse Effects of the Methoxsalen and Ultraviolent a Radiation on Spermatogenesis in Mice Iran J Reprod Med Vol. 13. No. 8. pp: 489-494, August 2015 Original article The adverse effects of the methoxsalen and ultraviolent A radiation on spermatogenesis in mice Mona Farhadi1 Ph.D., Homa Mohseni Kouchesfahani3 Ph.D., Abass Shockravi2 Ph.D., MosaeebForoozanfar3 Ph.D., Kazem Parivar3 Ph.D. 1. Department of Mcrobiology, Abstract Karaj Branch, Islamic Azad University, Karaj, Iran. Background: Different investigation showed that 5-methoxypsoralen and 8- 2. Faculty of Chemistry, Kharazmi methoxypsoralen reduce birth rates in the rats. University, Tehran, Iran. Objective: In this study we worked out the effect of methoxsalen together with 3. Department of Biology, ultraviolent A (UVA) radiation on mature Balb/C mice spermatogenesis. Kharazmi University, Tehran, Iran. Materials and Methods: The LD50 standard was determined 160 mg/kg and the UVA dose which causes erythema was calculated 0.046 J/cm2. A sub-lethal dose of 80 mg/kg of methoxsalen solution was injected intrapritoneally to mature mice and after one hour they were exposed to UVA radiation for 20 minutes. Experiments applied included methoxsalen alone, methoxsalen with UVA, UVA alone, sham group (a group received Tween 80), and control group (N=6). In all experimental groups except UVA alone group, injections were carried out, during two consecutive weeks. Serial cross sections (5 µm thickness) were prepared for morphological and histological studies. Tunica albuginea diameter, and number of type A and type B spermatogonia and histological investigation of the testes were measured. Results: Microscopical and statistical analyses showed significant anomalies among the experimental groups compared to control and sham group. These anomalies included decrease the body weight; increase the relative testis weight; and decrease the number of spermapogonia (type A and B), primary spermatocytes, spermatids and sperms in experimental groups I and II compared to control group. Our results showed the number of spermatozoa in experimental group I was 22.6±2.12, in Corresponding Author: experimental group II was 33.6±2.05 and in control group was 44.3±2.77 (p<0.05). Mona Farhadi, Department of Moreover in some experimental groups (I and II) shrinkage of seminiferous tubules Mcrobiology, Karaj Branch, and release of primary spermatocyte and spermatids were observed to the lumen of Islamic Azad University, Karaj, them. Iran. P.O.Box: 31485-313 Email: [email protected] Conclusion: It is concluded from the results of this work that treatment with Tel: (+98) 9122467389 methoxsalen with UVA can damage and disorganize seminiferous tubules and decrease spermatogenic cells. Received: 24 November 2013 Revised: 16 February 2015 Key words: Methoxsalen, UVA, Abnormality, Spermatogenesis. Accepted: 11 May 2015 Introduction known to be toxic to a wide range of organisms (7). In the last three decades soralens are a class of three rings, researchers were able to show that psoralens heterocyclic and planar compounds inhibit epidermal cell proliferation after UV P that occur naturally as secondary light irradiation (6). metabolites in various plant species (1, 2, 3, It has been shown that methoxsalene has 4) Methoxsalen (8-methoxypsoralen) together toxic effects on reproductive and with ultraviolet A (UVA) long-wave therapy developmental processes (8). Studies by (PUVA) is known to be a human carcinogen Diawara et al. (1997) showed that, oral based on sufficient evidence of administration of methoxsalen to male and carcinogenicity from studies in humans. In female rats reduces birth rate significantly. photo chemotherapy methoxsalen and UVA Also, 200 to 400 mg/Kg dosage of (320-400 nm) are used for treatment of some methoxsalen could reduce animal weight and epidermal proliferative disorders such as could change the histology of the liver, testes psoriasis and vitiligo (5, 6). Psoralens are and adrenal (9). In 2013 it was shown that Farhadi et al methoxsalen decreased mean level of methoxsalen with UVA and PUVA, while estrogen and progesterone significantly and it experimental group III were under UVA only. significantly reduced the number and diameter Injections were applied for two consecutive of corpus luteum and number of growing weeks. The animals of experimental groups (I, follicles (10). Ruta graveolens (RG) is one of II, III) were sacrificed 48 hours after the last the species of herbal medicinal families that injection, and their testes were removed and use for male contraception (11, 12). Long term fixed in Bouins’s fixative and embedding with administration of RG can decrease the weight paraffin. Then serial cross sections (5 µm of genital organs, sperm motility and sexual thickness) were prepared and slides were behavior in rat (13). RG plus 8-methoxy stained with H & E solutions for morphological psoralen (sodab) caused weight gain in and histological studies (15). The following observations were recorded: initial and final testicle and epydidim (14). These findings male body weights, testes weights, Tunica showed that psoralen could affect the male albuginea diameter, and number of and female reproductive systems. Despite of spermatogonia and histological investigation the long term application of furocoumarines of the testes. Morphometric measurements (methoxsalen, xanthotoxin, bergapten, were applied by light microscopy. Tubule isopimpinellin) in traditional medicine, the diameters of 100 nearly round seminiferous teratogenicity of methoxsalen alone or tubules were measured for each testis using together with UV radiation is not clear yet. an ocular micrometer at 250X. Diameter This study was applied to investigate the averaged for each rat for statistical analysis probable teratogenicity of methoxsalen on (16). All animal-related protocols were unmated male mature Balb/C mice. approved by Ethical Committee at Kharazmi University, Tehran, Iran. Materials and methods Statistical analysis In an experimental study in Kharazmi In all experiments, data were analyzed using University we used Methoxsalen with formula SPSS (Statistical Package for the Social of 9-methoxy-7H-furo [3, 2-g] [1]-benzopyran- Sciences, SPSS Inc., Chicago, IL, USA) 7-one that was purchased from Sigma Aldrich software, and one way ANOVA statistical (Germany) and Tween 80 was used as method. For each variable, means were solvent. The UVA source consisted of a calculated at the 5% level using LSD test. L40/79k (Osram) lamp emitting 7.632×10 (w/cm) at 50 cm distance. The UVA dose Results which causes erythema is 0.046 J/cm2. Male Balb/C mice were obtain from Pasture The results showed that body weight Institute (Experimental Animal Keeping reduced significantly in all experimental Center, Tehran, Iran) and were grown in the groups compared to the control group. animal room at temperature of 22-23°C, 50- Relative testes weight and the thickness of 55% humidity and lighting cycle of 12-h tunica albuginea, was significantly increased light/12-h dark. The animals were randomly (Figure 1) in experimental groups I and II, divided in three experimental, sham and while the testis volume and its length and control groups which all were unmated mature diameter did not show significant changes (Table I). The number of type A and B Balb/C mice (65 days old), 6 in each group. spermatogonia, primary spermatocytes, The LD50 standard was determined 160 spermatids and sperms were significantly mg/kg body weight and the UVA dose which reduced in all experimental groups, compared causes erythema was applied (0.046 g/cm). A to control group (Table II). In addition, PUVA sub-lethal dose of 80 mg/kg methoxsalen experience (experimental group I) and solution was injected intrapritoneally to mature methoxsalen alone expeience (experimental mice and after one hour the mice were group II) showed shrinkage of seminiferous exposed to UVA radiation for 20 minutes. tubules, release of primary spermatocytes and Experimental group I received methoxsalen sperms into the lumen, and disorganized only; experimental group II received seminiferous tubules (Figure 2). 490 Iranian Journal of Reproductive Medicine Vol. 13. No. 8. pp: 489-494, August 2015 Effect of methoxsalen on spermatogenesis Table I. Results of the effects of methoxsalen on the testes (mean±SE) Groups Body weight * Relative testis weight** Thickness of Tunica albuginea µm Controls 2.35±0.57 0.774±0.03 13.7±0.63 Sham 2.17±0.71 0.779±0.03 14.74±0.66 Methoxalen (experimental group I) -12.51±0.71 0.885±0.03 21.5±0.82 Methoxalen with UVA (experimental group II) -11.9±1.18 0.883±0.03 31.62±0.84 UVA (experimental group III) -1.28±0.57 0.771±0.02 19.7±0.77 * Body weight gain= (w2-w1)/w1×100: w1=animal weight before experiment, w2=animal weight after experiment and SE=standard error ** Relative testis weight =(testis weight/body weight)×100 b: Statistical difference to control group (p<0.05) UVA: Ultraviolent A Table II. Results of the effects of methoxsalen on the number of spermatogenic cells (mean±SE) No. of spermatogonia No. of spermatogonia No. of primary No. of No. of Groups Type A Type B spermatocyte spermatid spermatozoid Controls 2.4±0.12 13.52±0.67 18.2±0.82 66.5±2.81 44.3±2.77 Sham 2.2±0.11 13.22±0.65 17.4±0.79 64.9±2.63 44.6±2.76 Methoxalen (experimental group I) 1.44±0.13 9.6±0.715 15.14±0.73 39.9±2.67 22.6±2.12 Methoxalen with UVA(experimental group II) 1.28±0.11 7.64±0.497 12.04±0.71 46.8±2.84 33.6±2.05 UVA (experimental group III) 1.52±0.12 10.96±0.67 16.7±0.71 49.1±1.54 38.5±2.56 b: Statistical difference to control group (p<0.05). UVA: Ultraviolent A Figure 1. Photomicrograph of tunica albuginea of testis. Control (left), experimental: methoxsalen with UVA (right).
Load more

Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • Phototoxicity of 7-Oxycoumarins with Keratinocytes in Culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E
    Bioorganic Chemistry 89 (2019) 103014 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Phototoxicity of 7-oxycoumarins with keratinocytes in culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E. Heckc, Thomas M. Marianob, Robert D. Rappa, Michele Jettera, Keith Kardosa, Marilyn Whittemored, Eric Akyeaa, Ivan Jabine, Jeffrey D. Laskinb, Ned D. Heindela a Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA b Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA c Department of Environmental Science, New York Medical College, Valhalla, NY 10595, USA d Buckman Laboratories, 1256 N. McLean Blvd, Memphis, TN 38108, USA e Laboratoire de Chimie Organique, Université Libre de Bruxelles, B-1050 Brussels, Belgium ARTICLE INFO ABSTRACT Keywords: Seventy-one 7-oxycoumarins, 66 synthesized and 5 commercially sourced, were tested for their ability to inhibit 7-hydroxycoumarins growth in murine PAM212 keratinocytes. Forty-nine compounds from the library demonstrated light-induced 7-oxycoumarins lethality. None was toxic in the absence of UVA light. Structure-activity correlations indicate that the ability of Furocoumarins the compounds to inhibit cell growth was dependent not only on their physiochemical characteristics, but also Psoralens on their ability to absorb UVA light. Relative lipophilicity was an important factor as was electron density in the Methoxsalen pyrone ring. Coumarins with electron withdrawing moieties – cyano and fluoro at C – were considerably less 8-MOP 3 Phototoxicity active while those with bromines or iodine at that location displayed enhanced activity. Coumarins that were PAM212 keratinocytes found to inhibit keratinocyte growth were also tested for photo-induced DNA plasmid nicking.
    [Show full text]
  • Phototoxicity of 7-Oxycoumarins with Keratinocytes in Culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E
    Bioorganic Chemistry 89 (2019) 103014 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Phototoxicity of 7-oxycoumarins with keratinocytes in culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E. Heckc, Thomas M. Marianob, Robert D. Rappa, Michele Jettera, Keith Kardosa, Marilyn Whittemored, Eric Akyeaa, Ivan Jabine, Jeffrey D. Laskinb, Ned D. Heindela a Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA b Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA c Department of Environmental Science, New York Medical College, Valhalla, NY 10595, USA d Buckman Laboratories, 1256 N. McLean Blvd, Memphis, TN 38108, USA e Laboratoire de Chimie Organique, Université Libre de Bruxelles, B-1050 Brussels, Belgium ARTICLE INFO ABSTRACT Keywords: Seventy-one 7-oxycoumarins, 66 synthesized and 5 commercially sourced, were tested for their ability to inhibit 7-hydroxycoumarins growth in murine PAM212 keratinocytes. Forty-nine compounds from the library demonstrated light-induced 7-oxycoumarins lethality. None was toxic in the absence of UVA light. Structure-activity correlations indicate that the ability of Furocoumarins the compounds to inhibit cell growth was dependent not only on their physiochemical characteristics, but also Psoralens on their ability to absorb UVA light. Relative lipophilicity was an important factor as was electron density in the Methoxsalen pyrone ring. Coumarins with electron withdrawing moieties – cyano and fluoro at C – were considerably less 8-MOP 3 Phototoxicity active while those with bromines or iodine at that location displayed enhanced activity. Coumarins that were PAM212 keratinocytes found to inhibit keratinocyte growth were also tested for photo-induced DNA plasmid nicking.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Supplementary Tables, Figures and Other Documents
    Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients David Niedrig1,2, Ali Rahmany1,3, Kai Heib4, Karl-Dietrich Hatz4, Katja Ludin5, Andrea M. Burden3, Markus Béchir6, Andreas Serra7, Stefan Russmann1,3,7,* 1 drugsafety.ch; Zurich, Switzerland 2 Hospital Pharmacy, Clinic Hirslanden Zurich; Zurich Switzerland 3 Swiss Federal Institute of Technology Zurich (ETHZ); Zurich, Switzerland 4 INTLAB AG; Uetikon am See, Switzerland 5 Labor Risch, Molecular Genetics; Berne, Switzerland 6 Center for Internal Medicine, Clinic Hirslanden Aarau; Aarau, Switzerland 7 Institute of Internal Medicine and Nephrology, Clinic Hirslanden Zurich; Zurich, Switzerland * Correspondence: [email protected]; Tel.: +41 (0)44 221 1003 Supplementary Tables, Figures and Other Documents Figure S1: Example of credit-card sized pharmacogenomic profile issued to patients 1 Table S2: SNPs analyzed by the 16-gene panel test Gene Allele rs number ABCB1 Haplotypes 1236-2677- rs1045642 ABCB1 3435 rs1128503 ABCB1 rs2032582 COMT Haplotypes 6269-4633- rs4633 COMT 4818-4680 rs4680 COMT rs4818 COMT rs6269 CYP1A2 *1C rs2069514 CYP1A2 *1F rs762551 CYP1A2 *1K rs12720461 CYP1A2 *7 rs56107638 CYP1A2 *11 rs72547513 CYP2B6 *6 rs3745274 CYP2B6 *18 rs28399499 CYP2C19 *2 rs4244285 CYP2C19 *3 rs4986893 CYP2C19 *4 rs28399504 CYP2C19 *5 rs56337013 CYP2C19 *6 rs72552267 CYP2C19 *7 rs72558186 CYP2C19 *8 rs41291556 CYP2C19 *17 rs12248560 CYP2C9 *2 rs1799853 CYP2C9 *3 rs1057910 CYP2C9 *4 rs56165452 CYP2C9 *5 rs28371686 CYP2C9 *6 rs9332131 CYP2C9
    [Show full text]
  • Part IV: Basic Considerations of the Psoralens
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector THE CHEMISTRY OF THE PSORALENS* W. L. FOWLKS, Ph.D. The psoralens belong to a group of compoundsfled since biological activity of the psoralens and which have been considered as derivatives ofangelicins has been demonstrated. They appear coumarin, the furocoumarins. There are twelveto have specific biochemical properties which different ways a furan ring can be condensed withmay contribute to the survival of certain plant the coumarin molecule and each of the resultingspecies. Specifically these compounds belong to compounds could be the parent for a family ofthat group of substances which can inhibit certain derivatives. Examples of most of these possibleplant growth without otherwise harming the furocoumarins have been synthesized; but natureplant (2, 3, 5). is more conservative so that all of the naturally It is interesting that it was this property which occurring furocoumarins so far described turnled to the isolation of the only new naturally out to be derivativesof psoralen I or angelicinoccuring furocoumarin discovered in the United II (1). States. Bennett and Bonner (2) isolated tharn- nosmin from leaves of the Desert Rue (Tham- n.osma montana) because a crude extract of this 0 0 plant was the best growth inhibitor found among /O\/8/O\/ the extracts of a number of desert plants sur- i' Ii veyed for this property, although all the extracts showed seedling growth inhibition. One could I II speculate as to the role such growth inhibition plays in the economy of those desert plants These natural derivatives of psoralen and angeli-when survival may depend upon a successful cm have one or more of the following substituentsfight for the little available water.
    [Show full text]
  • Comparison of Two Diluents of 1% Methoxsalen in the Treatment of Vitiligo
    Net Letter eye care/cosmetic products should also be tested. Though anterior chamber after instillation of 10% phenylephrine phenylephrine is widely used by ophthalmologists in India hydrochloride solution. Br J Ophthalmol 1974;55:554-9. in nonhypertensive adults as a mydriatic agent to obtain 2. Wigger-Alberti W, Elsner P, Wuthrich B. Allergic contact maximum pupillary dilatation prior to fundus examination dermatitis to phenylephrine. Allergy 1998;53:217-8. 3. Yamamoto A, Harada S, Nakada T, Iijima M. Contact and assessment of refractory errors, allergic contact dermatitis to phenylephrine hydrochloride eyedrops. Clin dermatitis has not been reported from this country so far. Exp Dermatol 2004:29;200-1. This may be partly due to a low index of suspicion or failure 4. Herbst RA, Uter W, Pirker C, Geier J, Frosch PJ. Allergic and to perform patch tests in patients with transient and self- non-allergic periorbital dermatitis: Patch test results of the healing periorbital dermatitis. Information Network of the Department of Dermatology during a 5-year period. Contact Dermatitis 2004;51:13-9. RREFERENCESEFERENCES 5. Borch JE, Elmquist JS, Bindslevjensen C, Anderson KE. Phenylephrine and acute periorbital dermatitis. Contact 1. Agarwall Jl, Beveridge B. Liberation of iris pigment in the Dermatitis 2005;53:298-9. CComparisonomparison ofof twotwo ddiluentsiluents ooff 11%% mmethoxsalenethoxsalen inin thethe ttreatmentreatment ooff vvitiligoitiligo KKiraniran VV.. GGodseodse Consultant Dermatologist, Shree Skin Center and Laboratory, Mumbai, India AAddressddress fforor ccorrespondence:orrespondence: Dr. Kiran Godse, Shree Skin Center and Laboratory, 21/22, L market, Sector 8, Nerul, Navi Mumbai - 400 706, India. E-mail: [email protected] Sir, less than 20% of the body surface area.
    [Show full text]
  • Pharmaceuticals As Environmental Contaminants
    PharmaceuticalsPharmaceuticals asas EnvironmentalEnvironmental Contaminants:Contaminants: anan OverviewOverview ofof thethe ScienceScience Christian G. Daughton, Ph.D. Chief, Environmental Chemistry Branch Environmental Sciences Division National Exposure Research Laboratory Office of Research and Development Environmental Protection Agency Las Vegas, Nevada 89119 [email protected] Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Why and how do drugs contaminate the environment? What might it all mean? How do we prevent it? Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada This talk presents only a cursory overview of some of the many science issues surrounding the topic of pharmaceuticals as environmental contaminants Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada A Clarification We sometimes loosely (but incorrectly) refer to drugs, medicines, medications, or pharmaceuticals as being the substances that contaminant the environment. The actual environmental contaminants, however, are the active pharmaceutical ingredients – APIs. These terms are all often used interchangeably Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Office of Research and Development Available: http://www.epa.gov/nerlesd1/chemistry/pharma/image/drawing.pdfNational
    [Show full text]
  • Antiproliferative Effect of Angelica Archangelica Fruits Steinthor Sigurdssona,*, Helga M
    Antiproliferative Effect of Angelica archangelica Fruits Steinthor Sigurdssona,*, Helga M. Ögmundsdottirb, and Sigmundur Gudbjarnasona a Science Institute, University of Iceland, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland. Fax: +354 525 4886. E-mail: [email protected] b Molecular and Cell Biology Research Laboratory, Icelandic Cancer Society, Skogarhlid 8, IS-101 Reykjavik, Iceland * Author for correspondence and reprint requests Z. Naturforsch. 59c, 523Ð527 (2004); received December 21, 2003/February 9, 2004 The aim of this work was to study the antiproliferative effect of a tincture from fruits of Angelica archangelica and the active components using the human pancreas cancer cell line PANC-1 as a model. Significant dose-dependent antiproliferative activity was observed in µ the tincture with an EC50 value of 28.6 g/ml. Strong antiproliferative activity resulted from the two most abundant furanocoumarins in the tincture, imperatorin and xanthotoxin. The contribution of terpenes to this activity was insignificant. Imperatorin and xanthotoxin µ µ proved to be highly antiproliferative, with EC50 values of 2.7 g/ml and 3.7 g/ml, respec- tively, equivalent to 10 and 17 µm. The results indicate that furanocoumarins account for most of the antiproliferative activity of the tincture. Key words: Angelica archangelica, Xanthotoxin, Imperatorin Introduction their inhibiting effect on cytochrome P450, result- Angelica archangelica has been long and widely ing in drug-interactions (Guo et al., 2000; Koenigs used in folk medicine, and it is one of the most and Trager, 1998; Zhang et al., 2001). Imperatorin respected medicinal herbs in Nordic countries, has also been found to decrease chemically in- where it was cultivated during the Middle Ages, duced DNA adduct formation and may thus pos- and exported to other parts of Europe.
    [Show full text]
  • Evaluation of Methoxsalen in the Treatment of Vitiligo Irving D
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector EVALUATION OF METHOXSALEN IN THE TREATMENT OF VITILIGO IRVING D. LONDON, M.D. Montgomery, Atabamo The value of the psoralen compounds in theviolet light from a General Electric R.S. Sunlamp treatment of vitiligo has been documented inbulb. The amount of exposure was gradually in- this country since 1952 (1—6). Vitiligo is a dis-creased, based on the patient's tolerance. Another ease of unknown etiology in which the pigmentgroup was treated by topical application of one rarely if ever has been known to return spon-per cent methoxsalen paint over small patches of vitiligo followed by exposure to sunlight or sun- taneously to the involved areas (see p. 281).lamp. At first, both 8-methoxypsoralen (methox- No statistical analysis will be attempted in this salen) and 8-isoamylenoxypsoralen were usedpaper for several reasons. First, several patients together in capsules for oral administration andwere lost from view after several months of treat- mixed in a cream for topical use. Since 1955,ment. Some were seen at distant clinics and these only methoxsalen has been used, after Kanofrecords were not available during the preparation (5) found that this compound was as effectiveof this paper. A few patients had to stop taking when used alone as when combined with 8-the drug because of toxic reactions. Lastly, the isoamylenoxypsoralen. When methoxsalen, eithertechnics of administration of the psoralens were not always comparable. I shall, therefore, discuss applied topically or taken orally, is followed bynot statistics but the results in general of the exposure to gradually increasing doses of sun-various technies especially as they pertain to light or artificial ultraviolet light, gradual re-individual patients.
    [Show full text]
  • Psoralen Photochemistry and Nucleic Acid Structure
    0022-202X/ 8 1/ 770 1-00J9$02.00/ 0 THE JOURNAL OF I NV r, STIGATIVE DEIlMATOLOGY, 77:39-44, IH8 1 Vol. 77, No. I Copy righ t © 198 1 by The Williams & Wilkins Co. Printed ill U.S.A. Psoralen Photochemistry and Nucleic Acid Structure JOHN E. H EARST, PH.D. Departm.ent of Chemistry, University of California, B erkeley, California, U.S.A . Many new psorale n derivatives have b een synthesized nated in the production of many new psoralens, several of which in an effort to enhance their water solubility and their have superior photoreactivity with both DNA and RNA as binding to nucleic acids. Availability of the very soluble compared to TMP and 8-MOP. The 5 new derivatives shown strongly binding compounds has improved our abilities here are 4' adducts of TMP and their structW"es ru-e shown (3 - to follow the optical changes associated with the photo­ 7). T he complete characterization of methoxymethyltrioxsalen chemistry of psoralens with DNA. Changes in both ab­ (MMT, 4) , hydroxymethyltrioxsalen (HMT, 5) and aminome­ sorbance and fluoresce nce are prese nted in this r eview. thyltrioxsalen (AMT, 7) wi th respect to their reactivity with A kinetic model for the photochemistry concludes that nucleic acids, including a theoretical treatment, is described in the detailed kinetics is dominated by the equilibrium a recent paper by Isaacs et al [6]. A related set of soluble 8- constant for intercalation of the psoralen in the DNA, methoxypsoralen derivatives have been synthesized by Isaacs, the quantum yield for photoaddition to DNA once inter­ Chun, a nd Hearst [7] a nd ru'e listed as compounds 8-11.
    [Show full text]
  • Bergapten Drives Autophagy Through the Up-Regulation of PTEN
    De Amicis et al. Molecular Cancer (2015) 14:130 DOI 10.1186/s12943-015-0403-4 RESEARCH Open Access Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells Francesca De Amicis1,2†, Saveria Aquila1,2*†, Catia Morelli1, Carmela Guido2, Marta Santoro2, Ida Perrotta3, Loredana Mauro1, Francesca Giordano1, Alessandra Nigro3, Sebastiano Andò1,2* and Maria L. Panno1* Abstract Background: Bergapten (5-methoxypsoralen), a natural psoralen derivative present in many fruits and vegetables, has shown antitumoral effects in a variety of cell types. In this study, it has been addressed how Bergapten in breast cancer cells induces autophagic process. Results: In MCF7 and ZR-75 breast cancer cells Bergapten exhibited anti-survival response by inducing the autophagic process increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II. LC3-GFP, Acridine orange assay and transmission electron microscopy even confirmed the increased autophagosome formations in treated cells. Bergapten-induced autophagy is dependent by PTEN up-regulation, since silencing this gene, the induction of Beclin1 and the p-AKT/p-mTOR signal down-regulation were reversed. PTEN is transcriptionally regulated by Bergapten through the involvement of p38MAPK/NF-Y, as evidenced by the use of p38MAPK inhibitor SB203580, site-direct mutagenesis of NF-Y element and NF-Y siRNA. Furthermore NF-Y knockdown prevented Bergapten-induced acid vesicular organelle accumulations (AVOs), strengthening the role of this element in mediating autophagy. Conclusions: Our data indicate PTEN as a key target of Bergapten action in breast cancer cells for the induction of autophagy. These findings add further details on the mechanism of action of Bergapten, therefore suggesting that phytochemical compounds may be implemented in the novel strategies for breast cancer treatment.
    [Show full text]